Sanofi (SNY) Change in Inventory (2018 - 2025)

Sanofi has disclosed Change in Inventory across 8 years of filings, most recently posting -$45.4 million for Q4 2025.

• In Q4 2025, Change in Inventory rose 91.09% year-over-year to -$45.4 million; the TTM figure through Dec 2025 stood at -$2.4 billion (up 12.98% YoY), while the FY2025 annual figure was -$45.4 million, up 91.21% from the prior year.
• Change in Inventory came in at -$45.4 million for Q4 2025 at Sanofi, up from -$509.7 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of -$45.4 million in Q4 2025 to a low of -$945.8 million in Q4 2022.
• Average Change in Inventory over 5 years is -$568.2 million, with a median of -$509.7 million recorded in 2024.
• Year-over-year, Change in Inventory plunged 131.58% in 2022 and soared 91.09% in 2025.
• Over 5 years, Change in Inventory stood at -$408.4 million in 2021, then sank by 131.58% to -$945.8 million in 2022, then grew by 1.48% to -$931.8 million in 2023, then soared by 45.3% to -$509.7 million in 2024, then soared by 91.09% to -$45.4 million in 2025.
• Per Business Quant data, the three most recent Change in Inventory figures were -$45.4 million in Q4 2025, -$509.7 million in Q4 2024, and -$931.8 million in Q4 2023.